Harmar Village: Unmonitored Psych Meds Given - PA
Resident R122 was prescribed two antidepressants, two doses of an antipsychotic, and an anti-anxiety medication within a week of his March 27 admission. None of the prescriptions included documented medical reasons for their use, despite the resident's complex medical history including paraplegia, depression, anxiety disorder, and bipolar disorder.
The medication regimen included buspirone tablets twice daily for anxiety, escitalopram once daily as an antidepressant, mirtazapine at bedtime for depression, and two separate doses of quetiapine — a powerful antipsychotic given both at bedtime and once daily.
Facility staff failed to document whether any non-drug interventions were attempted before resorting to psychiatric medications. They also failed to monitor whether the drugs were working or causing harmful side effects.
The facility's own policy, dated August 15, 2025, required staff to monitor and document residents' behaviors, the effectiveness of both drug and non-drug interventions, and the potential for gradually reducing psychiatric medication doses.
None of this monitoring occurred for Resident R122.
Registered Nurse Assessment Coordinator Employee E17 confirmed during an April 1 interview that the resident's psychiatric medication orders lacked documented medical justification. The nurse also acknowledged that clinical records contained no evidence of intervention monitoring, medication effectiveness tracking, or side effect surveillance.
The following day, Administrator Employee E5 and the Director of Nursing both confirmed the facility had failed to ensure the resident's psychiatric medications were medically necessary and properly monitored.
Psychiatric medications carry significant risks for elderly residents, particularly those with complex medical conditions like paraplegia. Antipsychotics can cause sedation, falls, and movement disorders. Multiple antidepressants can interact dangerously with each other and other medications.
Federal regulations require nursing homes to ensure residents are free from unnecessary psychotropic drugs and that any such medications are used only when medically indicated with appropriate monitoring.
The inspection occurred just one week after Resident R122's admission, suggesting the medication problems began immediately upon his arrival at the facility. The rapid prescription of multiple psychiatric drugs without proper documentation or monitoring raises questions about the facility's medication management practices for vulnerable residents.
State inspectors classified the violation as causing minimal harm or potential for actual harm, affecting few residents. However, the failure to monitor psychiatric medications can lead to serious complications including oversedation, dangerous drug interactions, and masking of underlying medical conditions.
The facility's Administrator and Director of Nursing acknowledged their failure to ensure proper psychiatric medication management during interviews with inspectors. Their admissions came after the Registered Nurse Assessment Coordinator had already confirmed the lack of medical justification and monitoring documentation.
Resident R122's case highlights broader concerns about psychiatric medication use in nursing homes. Without proper monitoring and documentation, facilities cannot determine whether residents are receiving appropriate care or suffering from preventable medication-related harm.
The inspection report does not indicate whether Resident R122 experienced adverse effects from the unmonitored psychiatric medications or whether the facility has since implemented proper monitoring procedures.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Harmar Village Health & Rehab Center from 2026-04-03 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: August 5, 2026 · Our methodology
HARMAR VILLAGE HEALTH & REHAB CENTER in CHESWICK, PA was cited for violations during a health inspection on April 3, 2026.
Resident R122 was prescribed two antidepressants, two doses of an antipsychotic, and an anti-anxiety medication within a week of his March 27 admission.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.